LBB Specialties Expands Industrial Specialties Portfolio with Kemitura
NORWALK, Conn., Feb. 24, 2026 /PRNewswire/ -- LBB Specialties (LBBS), a North American…
MSIG USA and MSI Japan Partner with IFC to Support Expanded Lending in Emerging Markets
TOKYO and NEW YORK, Feb. 24, 2026 /PRNewswire/ -- MSIG USA and Mitsui Sumitomo…
Docusign Partners with Anthropic to Bring Its Intelligent Contract Workflows to Cowork
SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Docusign (Nasdaq: DOCU), the leader in…
3iQ Announces Earlier Than Anticipated Closing of Previously Disclosed Transaction with Coincheck Group N.V.
TORONTO, Feb. 24, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer…
TIMES PRIME PARTNERS WITH CRUNCHYROLL TO BRING PREMIUM ANIME STREAMING TO MEMBERS
NEW DELHI, Feb. 24, 2026 /PRNewswire/ -- Times Prime, India's leading lifestyle…
OVS Expands Retail Presence in India with Strategic Entry into Mumbai
~Launch marks the brand's second store in India following its New Delhi…
Cholan Tours Breaks Industry Barriers with India’s First Women Chauffeur-Driven Tours
CHENNAI, India, Feb. 24, 2026 /PRNewswire/ -- One of the most reputable destination…
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
February 23, 2026 17:10 ET | Source: Kyntra Bio FG-3246 and enzalutamide…
Colgate-Palmolive partners with Haryana Government to advance Oral Health Education for 57 Lakh School Children
NEW DELHI, Feb. 23, 2026 /PRNewswire/ -- Colgate-Palmolive (India) Limited has announced…
GovSignals Achieves DoW IL5 Authorization with Second Front Systems, Bringing Secure Acquisition AI to Defense and Federal Missions
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- GovSignals, the acquisition AI…
